Key stats
About TIGER CHINA BIOTECH SOLACTIVE
Expense ratio
0.49%
Home page
Inception date
Dec 3, 2020
ISIN
KR7371470006
This ETF seeks to replicate the daily performance of the SOLACTIVE China Biotech Index by investing in China,Hong Kong listed equity.or ADR
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks60.33%
Health Technology60.33%
Bonds, Cash & Other35.99%
Cash32.13%
ETF2.19%
Miscellaneous1.67%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history